Anticancer drugs inhibit induction of NO synthase in rat in vivo

General Pharmacology

Volumn 32, Issue 2, 1999, Pages 185-188

  Inagaki, Rika ^a   Taniguchi, Takanobu ^a   Sakai, Toyohiko ^a   Hayashi, Nobushige ^a   Ishii, Yasushi ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

4' Epi doxorubicin; Mitomycin C; Nitric oxide synthase

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN; LIPOPOLYSACCHARIDE; MITOMYCIN C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCITES CELL; BONE MARROW CELL; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME LOCALIZATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ENZYME INDUCTION; EPIRUBICIN; LIPOPOLYSACCHARIDES; MALE; MITOMYCIN; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0032988005     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00179-7     Document Type: Article

References (24)

1. Bodesteiner D.C., Doolittel G.C. Adverse haematological complications of anticancer drugs. clinical presentation, management and advoidance Drug Saf. 8:1993;213-224.
2. Gilman A.G., Hardman J.G., Limbird L.E. Antineoplastic agents. Chabner B.A., Allegra C.J., Curt G.A., Calabres P. Goodman and Gilman's the pharmacological basis of therapeutics. 1996;1225-1287 McGraw-Hill, New York.
3. Granger D.L., Hibbs J.B. Jr., Perfect J.R., Durack D.T. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest. 85:1990;264-273.
4. Green S.J., Meltzer M.S. Jr., Hibbs J.B., Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 144:1990;278-283.
5. Heel K.A., Hall J.C. Peritoneal defences and peritoneum-associated lymphoid tissue. Br J Surg. 83:1996;1031-1036.
6. Hibbs J.J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxity. role for L-arginine deiminase and imino nitrogen oxidation to nitrite Science. 235:1987;473-476.
7. Iyer V.N., Szybalski W. A molecular mechanism of mitomycin action. linking of complimentary DNA strands Proc Natl Acad Sci USA. 50:1963;355-362.
8. Johnstone J.R.B. Monocytes and macrophages. N Engl J Med. 318:1988;747-752.
9. Kennedy K.A., McGurl J.D., Leondaridis L., Alabaster O. pH-dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Res. 45:1985;3541-3547.
10. Kirikae T., Ojima I., Kirikae F., Ma Z., Kuduk S.D., Slater J.C., Takeuchi C.S., Bounaud P.-Y., Nakano M. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages. Biochem Biophys Res Commun. 227:1996;227-235.
11. Liew F.Y., Millott S., Parkinson C., Palmer R.M.J., Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol. 144:1990;4794-4797.
12. Moncada S., Palmer R.M.J., Higgs E.A. Biosynthesis of nitric oxide from L-arginine. a pathway for the regulation of cell function and communication Biochem Pharmac. 38:1989;1709-1715.
13. Nakamura H., Hashimoto T., Oi H., Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 170:1989;783-786.
14. Ogura T., Tatemichi M., Esumi H. TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. Biochem Biophys Res Commun. 233:1997;788-791.
15. Ramussen L., Arvin A. Chemotherapy-induced immunosupression. Environ Health Perspect. 43:1982;21-25.
16. Rogers N.E., Ignarro L.J. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun. 189:1992;242-249.
17. Rostad M.E. Current strategies for managing myelosuppression in patients with cancer. Oncol Nurs Forum. 18(suppl. 2):1991;7-15.
18. Sakai T., Muramastu I., Hayashi N., Ishii Y. Inhibition of NO synthase induction by an anticancer drug 4′-epi-doxorubicin in rats. Gen Pharmac. 27:1996;1367-1372.
19. 2+-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
20. Schmidt H.H., Walter U. NO at work. Cell. 78:1994;919-925.
21. Takakura K., Goto Y., Kigoshi S., Muramatsu I. Comparison between the effects of treatment in vitro and in vivo with lipopolysaccharide on responsiveness of rat thoracic aorta. Circ Shock. 42:1994;141-146.
22. Topley N., Liberek T., Davenport A., Li F.K., Williams J.D. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl. 56:1996;S17-S21.
23. Uchida H., Oishi H., Matsuo N., Nishimine K., Ohue S., Nishimura Y., Maeda M., Yoshida T. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 13:1990;140-145.
24. Van der Wall E., Beijnen J.H., Rodenhuis S. High-dose chemotherapy regimens for solid tumors. Cancer Treat Rev. 21(2):1995;105-132.